Abstract:Abstract Introduction Methamphetamine use adversely effects the cardiovascular system leading to pulmonary hypertension and heart failure (HF) due to non-ischemic dilated cardiomyopathy with reduced ejection fraction (EF). Despite this, many methamphetamine (MA) users with HF have preserved EF and the adverse effects of their MA use may be overlooked. Subclinical cardiac dysfunction associated with MA use may become clinically apparent in patients experiencing a significant physiological stress like burn injury. We hypothesize that transthoracic echocardiogram (TTE) findings and outcomes of MA positive patients will be worse than those of MA negative patients. Methods Following IRB approval, data was collected on all patients admitted for burn injuries who had admission TTEs between January 2015 and December 2019. Patients were divided into two groups based on admission drug screen positivity for MA. Data collected included TTE findings, patient demographics, percent total body surface area (%TBSA) burned, length of stay (LOS), hospital charges, and mortality. The two groups were then matched based on age and burn %TBSA. Analysis on the total population and the matched data set was conducted with SAS statistical software using Chi-square, Fisher Exact, and Wilcoxon 2-sample tests. Results A total of 417 patients with TTEs were included, 295 MA negative and 122 MA positive (29.3%). In the total population, MA positive patients were younger (p< 0.0001), had larger burns (p=0.003), more inhalation injury (p=0.002), less aortic regurgitation (p< 0.0001), higher left ventricular EF (p=0.01), higher hospital charges (p=0.003), and lower mortality (p=0.02) than their MA negative counterparts. In the group matched for age and %TBSA, there was no significant difference in inhalation injury, sex, race, or BMI between groups. The MA negative group had significantly more patients with aortic regurgitation (p=0.02). All other TTE findings were not significantly different. No significant differences were found in LOS (p=0.25), operations (p=0.08), charges (p=0.19), or mortality (p=0.14). The circumstances of burn injuries were significantly different (p=0.03), where MA positive patients were more likely to be burned as a result of suspected assault or self-injury and MA negative patients were more likely to have accidental workplace related burns. Conclusions Patients who tested positive for MA on admission were younger and had larger burns. When controlled by matching, there were no differences in TTE findings or clinical outcomes related to testing MA positive. Applicability of Research to Practice Admission drug screen positivity for methamphetamine alone may not be an indication for obtaining TTE.

The Body Mass Index, Blood Pressure, and Fasting Blood Glucose in Patients with Methamphetamine Dependence

Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A 1H MRS Study

Volumetric abnormalities of grey matter in methamphetamine dependent patients

Effect of methamphetamine on the fasting blood glucose in methamphetamine abusers

Gender Differences in Socio-Demographic and Clinical Characteristics of Methamphetamine Inpatients in a Chinese Population

Epidemiological Characteristics and Risk Factors of Methamphetamine-Associated Psychotic Symptoms

The Cognitive Impairments and Psychological Wellbeing of Methamphetamine Dependent Patients Compared with Health Controls

Profile of Psychiatric Symptoms in Methamphetamine Users in China: Greater Risk of Psychiatric Symptoms with a Longer Duration of Use.

An Investigation of Cigarettes Smoking Behavior and Nicotine Dependence among Chinese Methamphetamine Users in Two Provinces.

Genome-Wide DNA Methylation Analysis in Male Methamphetamine Users with Different Addiction Qualities

Oral Microbiota Profile of Individuals Who Abuse Methamphetamine

A Research Of Methamphetamine Induced Psychosis In 1,430 Individuals With Methamphetamine Use Disorder: Clinical Features And Possible Risk Factors

Associations Between Methamphetamine and Alcohol Use Disorder, Suicidal Ideation, and Lowered Quality of Life in Methamphetamine Users

Methamphetamine (MA) use and MA-induced psychosis are associated with increasing aberrations in the compensatory immunoregulatory system, interleukin-1α, and CCL5 levels

Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.

Methamphetamine (MA) use, MA dependence, and MA-induced psychosis are associated with increasing aberrations in the compensatory immunoregulatory system and interleukin-1α and CCL5 levels

Effects of Methamphetamine on Within- and Between-Network Connectivity in Healthy Adults

701 Effect of Methamphetamine Use on Transthoracic Echocardiographic Findings in Burn Patients

Relationship Between the Duration of Methamphetamine Use and Psychotic Symptoms: A Two-Year Prospective Cohort Study.

Altered patterns of fractional amplitude of low-frequency fluctuation and regional homogeneity in abstinent methamphetamine-dependent users

The Potential Regulatory Network of Glutamate Metabolic Pathway Disturbance in Chinese Han Withdrawal Methamphetamine Abusers